NPCE
Neuropace Inc
14.20$
-3.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +165.2% | +138.7% | -14.6% | -5.7% | -12.1% | +11.5% | |
| – | +169.3% | +143.4% | -26.4% | -5.1% | -12.3% | +15.7% | |
| – | +540.1% | -27.3% | -65.6% | +173.4% | -25.6% | +61.5% | |
| – | +647.8% | +203.5% | -33.0% | -14.2% | -20.6% | +15.7% | |
| – | +39.5% | -15.5% | +5.5% | +64.6% | +4.4% | +14.2% | |
| – | -12.5% | +13.2% | +24.2% | +15.5% | +19.3% | +26.3% | |
| – | -36.4% | +17.1% | +76.5% | – | – | – | |
| – | +35.5% | -70.5% | +32.1% | +9.7% | -0.4% | -0.1% | |
| – | -87.2% | -3.1% | +18.0% | +47.9% | -6.6% | +17.5% | |
| – | -96.7% | – | – | +15.0% | +14.3% | +13.8% | |
| – | +5.1% | +45.2% | +55.8% | +8.6% | +26.7% | -24.9% | |
| – | – | -1.9% | +6.2% | +7.6% | +4.5% | -1.1% | |
| – | – | – | -52.7% | -40.6% | -61.2% | +137.5% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +49.6% | +48.1% | +5.1% | +12.7% | +12.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.